HLMVX
Price
$38.05
Change
+$0.09 (+0.24%)
Updated
Dec 3 closing price
Net Assets
579.87M
RNPCX
Price
$71.95
Change
+$0.37 (+0.52%)
Updated
Dec 3 closing price
Net Assets
162.64B
Interact to see
Advertisement

HLMVX vs RNPCX

Header iconHLMVX vs RNPCX Comparison
Open Charts HLMVX vs RNPCXBanner chart's image
Harding Loevner Global Equity Inst
Price$38.05
Change+$0.09 (+0.24%)
VolumeN/A
Net Assets579.87M
American Funds New Perspective R3
Price$71.95
Change+$0.37 (+0.52%)
VolumeN/A
Net Assets162.64B
HLMVX vs RNPCX Comparison Chart in %
View a ticker or compare two or three
VS
HLMVX vs. RNPCX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLMVX is a Buy and RNPCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPCX has more cash in the bank: 163B vs. HLMVX (580M). HLMVX pays higher dividends than RNPCX: HLMVX (0.30) vs RNPCX (0.21). HLMVX was incepted earlier than RNPCX: HLMVX (16 years) vs RNPCX (24 years). RNPCX (1.06) is less costly to investors than HLMVX (0.87). HLMVX is a more actively managed with annual turnover of: 27.00 vs. RNPCX (24.00). RNPCX has a lower initial minimum investment than HLMVX: RNPCX (250) vs HLMVX (100000). RNPCX annual gain was more profitable for investors over the last year : 11.50 vs. HLMVX (-15.84). RNPCX return over 5 years is better than : 22.60 vs. HLMVX (-19.75).
HLMVXRNPCXHLMVX / RNPCX
Total Expense Ratio0.861.0681%
Annual Report Gross Expense Ratio0.871.0682%
Fund Existence16 years24 years-
Gain YTD12.27519.77762%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets580M163B0%
Annual Yield % from dividends0.300.21143%
Returns for 1 year-15.8411.50-138%
Returns for 3 years13.3443.9730%
Returns for 5 years-19.7522.60-87%
Returns for 10 years19.7990.0322%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATNM1.450.07
+5.07%
Actinium Pharmaceuticals
AXSM147.815.72
+4.03%
Axsome Therapeutics
ARLO14.270.38
+2.74%
Arlo Technologies
TLSI6.43-0.02
-0.31%
TriSalus Life Sciences
MNSBP24.85-0.12
-0.50%
MainStreet Bancshares